41372-34-3 Usage
Uses
Used in Organic Synthesis:
4-Amino-cis-2-Buten-1-ol is used as a key intermediate in organic synthesis for its ability to participate in a variety of chemical reactions, facilitating the creation of complex organic compounds.
Used in Pharmaceutical Preparation:
In the pharmaceutical industry, 4-Amino-cis-2-Buten-1-ol is utilized as a building block for the synthesis of various pharmaceuticals, contributing to the development of new drugs and medicines.
Used in Chiral Compound Creation:
Due to its specific stereochemical properties stemming from the cis configuration of the double bond, 4-Amino-cis-2-Buten-1-ol is used as a precursor in the creation of chiral compounds, which are essential in many biochemical and pharmaceutical applications.
Used in Chemical Reactions and Synthetic Processes:
4-Amino-cis-2-Buten-1-ol is employed as an important intermediate in a range of chemical reactions and synthetic processes, playing a crucial role in the synthesis of target molecules with desired properties.
Check Digit Verification of cas no
The CAS Registry Mumber 41372-34-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,3,7 and 2 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 41372-34:
(7*4)+(6*1)+(5*3)+(4*7)+(3*2)+(2*3)+(1*4)=93
93 % 10 = 3
So 41372-34-3 is a valid CAS Registry Number.
41372-34-3Relevant academic research and scientific papers
Al-Shuhaib, Zainab,B?ckemeier, Henning,Coghlan, Lawrence,D?rksen, Elina,Jones, Iestyn V.,Murphy, Patrick J.,Nash, Robert,Page, James M.
, p. 6716 - 6718 (2013)
The Pd-mediated π-allyl cyclisation of bis-Cbz- and bis-Boc-protected guanidines 4 and 14b led to the formation of five- and six-membered heterocycles 5 and 17 in high yields.
Discovery of a new class of macrocyclic antagonists to the human motilin receptor
Marsault, Eric,Hoveyda, Hamid R.,Peterson, Mark L.,Saint-Louis, Carl,Landry, Annick,Vézina, Martin,Quellet, Luc,Wang, Zhigang,Ramaseshan, Mahesh,Beaubien, Sylvie,Benakli, Kamel,Beauchemin, Sophie,Déziel, Robert,Peeters, Théo,Fraser, Graeme L.
, p. 7190 - 7197 (2007/10/03)
A novel class of macrocyclic peptidomimetics was identified and optimized as potent antagonists to the human motilin receptor (hMOT-R). Well-defined structure-activity relationships allowed for rapid optimization of potency that eventually led to high aff
